Edition:
India

Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)

BHVN.N on New York Stock Exchange

37.42USD
21 Aug 2019
Change (% chg)

$0.04 (+0.11%)
Prev Close
$37.38
Open
$37.84
Day's High
$38.20
Day's Low
$37.04
Volume
100,223
Avg. Vol
199,143
52-wk High
$67.86
52-wk Low
$29.17

Select another date:

Sat, Jul 20 2019

Photo

Biohaven's treatment for Lou Gehrig's disease fails to win FDA nod

Biohaven Pharmaceutical Holding Co Ltd said on Friday the U.S. health regulator failed to approve its treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease, sending its shares down nearly 6% in extended trading.

Biohaven's treatment for Lou Gehrig's disease fails to win FDA nod

Biohaven Pharmaceutical Holding Co Ltd said on Friday the U.S. health regulator failed to approve its treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease, sending its shares down nearly 6% in extended trading.

Biohaven's treatment for Lou Gehrig's disease fails to win FDA nod

July 19 Biohaven Pharmaceutical Holding Co Ltd said on Friday the U.S. health regulator failed to approve its treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease, sending its shares down nearly 6% in extended trading.

Select another date: